Moreover, the expression of HLA-DR and CD83 on ILC2 could be the basis of an agonist effect necessary for the activation of T-cells, as described for MHC-II and CD86 (26), and contribute to T2 immune response in FA (41). The gene discussed is CD83; the disease is Friedreich ataxia.